Laurent Kodjikian

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial

Laurent Kodjikian, Eric H. Souied, G. Mimoun et al. · Ophthalmology · 2013 · 251 citations

Ranibizumab Versus Bevacizumab, Ocular Disease, Ophthalmology +5

Long-Term Ocular Prognosis in 327 Children With Congenital Toxoplasmosis

Martine Wallon, Laurent Kodjikian, Christine Binquet et al. · PEDIATRICS · 2004 · 226 citations

ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis

Pierre Quartier, Amandine Baptiste, V. Despert et al. · Annals of the Rheumatic Diseases · 2017 · 163 citations